Abattis Bioceuticals Corp. has signed a letter of intent (the LOI) with Kanabe Corp. to provide Kanabe with cannabinoids as well as formulation, manufacturing, analytical and regulatory services to support the development and commercialization of Kanabe's products. Kanabe is a Calgary-based manufacturer of various health and wellness products, including topicals, sublingual oils and other skin-care products. Pursuant to the LOI, Abattis and Kanabe have agreed to negotiate in good faith the terms of a definitive research services agreement respecting the terms of their partnership.
"We hope our partnership with Kanabe will enable it to scale its manufacturing capacity, allowing it to enter new retail distribution channels, including storefronts throughout Canada and online stores. Kanabe's product line will focus on the adult-use market and will be based on Abattis's downstream cannabis solutions, resulting in a premium product and unparalleled customer experience", stated Rob Abenante, President and CEO of Abattis. "This is the latest example of our fully-integrated suite of services supporting manufacturers of cannabis- and hemp-infused products from formulation to distribution", added Mr. Abenante.
"Kanabe believes this partnership will enhance our formulations, with access to Abattis's full range of services and industry leading technologies, and result in premium quality products. Concurrently with our work with Abattis, we are working to secure distribution agreements for our line of health and wellness products with major retail chains, one of which has 100+ locations throughout various provinces. We are also poised and well situated to provide our products in distribution channels overseen by provincial commissions", stated Daniel Laferriere, CEO and founder of Kanabe Corp.
Click here to read the original article.